Introduction
Infections due to A. baumannii often prove difficult to treat due to high level of resistance to multiple antibiotics as a result of both intrinsic and acquired mechanisms. According to Rao et al, A. baumannii isolates showed 100% resistance to imipenem, followed by cephotaxime (89%), amikacin (80%) and ciprofloxacin (73%).
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Therefore, the aim of the present study was to detect gelatinase production, biofilm formation and antimicrobial susceptibility of Acinetobacter species isolated from various clinical specimens.
Material and Methods
Clinical samples were collected from patients admitted in BSMMU and from patients admitted in the Burn unit of Dhaka Medical College Hospital. Samples included were tracheal aspirate, blood from central venous catheter (CVC), peripheral blood, urine from catheterized patients , pus, ascitic fluid, cerebrospinal fluid, sputum, catheter tip, and wound throat and aural swabs. Laboratory works were performed in the department of Microbiology & Immunology, BSMMU, Dhaka between January 2010 to December 2010.
Microbiological methods
a. Identification of Acinetobacter: Suspected colonies of Acinetobacter species were identified by colony morphology, Gram staining, motility, oxidase, catalase, citrate utilization, indole and urease tests, glucose oxidation in Krigler Iron Agar (KIA) media and biochemical tests in oxidation and fermentation media (OF media). These identification schemes were done as per standard techniques.
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b. Gelatinase activity: Gelatinase production was detected by inoculating Acinetobacter isolates on the Luria Bertani agar media containing gelatin (30 g/l). After inoculation the plates were incubated overnight at 37 0 C and then cooled for 5 hours at 4 0 C. The appearance of a turbid halo around the colonies was considered positive for gelatinase production. 5 Serratia spp. was used as positive control and E. coli was used as negative control in this test.
c. Biofilm assay: Qualitative production of biofilm by Acinetobacter was assayed by tissue culture plate method as described by Toledo et al., 2001 .
9 Biofilm formations is considered positive when a visible film lines the wall and bottom of the tube. In this method biofilm formation is detected by measuring optical density with ELISA reader. 10 Isolates were grown overnight at 37 0 C in Brain Heart Infusion Broth (BHIB) with 0.25 % glucose. The culture was diluted at a ratio of 1:20 in fresh BHIB with 0.25% glucose. 200 µl of this suspension was inoculated in a sterile 96 well flat bottomed polystyrene microtiter plate. Then the plate was incubated at 37 0 C for 24 hours. Wells were washed with phosphate buffered solution (PBS) three times. Non-adherent cells were removed by washing with PBS. Then the microtiter plate was dried in an inverted position. After drying, the plate was stained with 0.5% Crystal violet (CV) for 15 minutes at room temperature. CV allowed visualization of the attachment pattern of bacteria in microtiter plate. Wells were rinsed once more. Then 200 µl of ethanol/acetone (80:20, v/v) was added in each well to solubilize CV. The optical density (OD) at 550 nm was determined using a microtiter reader. Each assay was performed in triplicate and repeated twice. Staphylococcus. epidermidis was taken as a positive control and Salmonella typhi was taken as a negative control. The cut off value (ODc) was established and was defined as mean OD + 3xSD of the negative controls. Final OD value of a tested strain was expressed as mean OD value of the triplicate assays. Any OD above the cut off value was indicative of biofilm production. 12 Amoxicillin (10µg), ciprofloxacin (5 µg), gentamicin (10µg), ceftriaxone (30µg), ceftazidime (30µg), cefuroxime (30µg), cefotaxime (30µg), amikacin (30µg), aztreonam (30µg), imipenem (10µg), netilmicin (30µg) and colistin (10µg) discs were used.
Results
In the present study, Acinetotbacter species were predominantly isolated from tracheal aspirate (54.3%) followed by CVC blood (36.4%), peripheral blood (19.2%), urine (21.2%), wound swab (25.0%), pus, 5 (13.9%). No growth of Acinetobacter species were detected in other samples namely ascitic fluid, sputum, aural swab, oral swab, burn samples, cerebrospinal fluid and catheter tips. All the 52 Acinetobacter isolates were negative for gelatinase production but 39 (75.0%) Acinetobacter isolates showed biofilm production ( Table-1 ). The rate of biofilm production by isolated Acinetobcter from different clinical samples is shown in Table- 1. All the Acinetobacter isolates (100%) were resistant to ceftazidime, cefotaxime, cefuroxime and ceftriaxone. Higher level of resistance was also recorded for amoxicillin (98.1%), aztreonam (98.1%), gentamicin (90.4%), ciprofloxacin (73.1%), amikacin (57.6%), netilmicin (53.8%) and imipenem (44.2%). Only 3.8% of isolated Acinetobacter were resistant to colistin.
Discussion
Acinetobacter, once considered to be a low virulent pathogen, is currently a major problem in hospital especially in ICU. Their emergence as significant pathogen seems to be related to their survival ability and to their ability to develop resistance rapidly to the major groups of antibiotics.
In this current study, out of 52 Acinetobacter isolates, none produced gelatinase while 75% was positive for biofilm production. Sechi et al found no gelatinase activity and biofilm formation by 80% Acinetobacter isolates. 13 Cevahir et al detected gelatinase activity in 14.0% and biofilm formation in 74.4% Acinetobacter isolates.
14 Acinetobacter isolated from CVC blood, peripheral blood and tracheal aspirates showed higher biofilm production (84-100%). The presence of indwelling medical devices increases the risk for biofilm formation and subsequent infection especially in the ICU. 7 Biofilm production in Acinetobacter species might promote increased colonization and persistence leading to higher rate of device related infections.
This study showed that 100% of the isolated Acinetobacter species were resistant to ceftazidime, cefotaxime, cefuroxime and ceftriaxone. High level of resistance was recorded for amoxicillin, aztreonam, gentamicin, ciprofloxacin, amikacin and netilmicin (53.8%). However, low resistance to imipenem (44.2%) and colistin (3.8%) was observed. Lone et al 15 reported high level of resistance of Acinetobacter isolates to gentamicin (61.5%), cefotaxime (65.8%), ceftriaxone (61.5%) and ciprofloxacin (69.2%). Amikacin, cefoperazone+sulbactam and imipenem showed maximum susceptibility with an overall resistance rate of 17%17%, 11.5%, and 1.5% respectively. Most of the Acinetobacter species were multidrug resistant. Multidrug resistant isolates are increasing day by day.
